Dual-targeting strategies for cancer and diabetes: Converging pharmacological pathways and repurposed therapies.
Saved in:
| Title: | Dual-targeting strategies for cancer and diabetes: Converging pharmacological pathways and repurposed therapies. |
|---|---|
| Authors: | Bhatti GK; Department of Medical Lab Technology, University Institute of Allied Health Sciences, Chandigarh University, Mohali, 140413, Punjab, India; University Centre for Research and Development, Chandigarh University, Mohali, 140413, Punjab, India., Ahmed I; Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India., Sehrawat A; Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India., Sharma PK; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, 303002, India; Amity Center of Nanobiotechnology and Nanomedicine, Amity University Rajasthan, Jaipur, India., Kandimalla R; Department of Biochemistry, Kakatiya Medical College, Warangal, India., Kaura KS; Department of Urology, All India Institute of Medical Sciences, Bathinda, Punjab, India. Electronic address: kskaura@gmail.com., Bhatti JS; Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India. Electronic address: jasvinder.bhatti@cup.edu.in. |
| Source: | Molecular aspects of medicine [Mol Aspects Med] 2026 Jun; Vol. 109, pp. 101464. Date of Electronic Publication: 2026 Mar 06. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Country of Publication: England NLM ID: 7603128 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9452 (Electronic) Linking ISSN: 00982997 NLM ISO Abbreviation: Mol Aspects Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
